Patents by Inventor Erik RYTTING

Erik RYTTING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210393536
    Abstract: Certain embodiments are directed to methods and compositions related to delivery of therapeutic agents via syncytiotrophoblast-derived extracellular vesicles (EVs).
    Type: Application
    Filed: June 23, 2021
    Publication date: December 23, 2021
    Inventors: Tatiana Nanovskaya, Erik Rytting, Mansi Shah, Svetlana Patrikeeva, Xiaoming Wang
  • Patent number: 11117865
    Abstract: Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.
    Type: Grant
    Filed: June 16, 2019
    Date of Patent: September 14, 2021
    Assignee: Board of Regents, The University Of Texas System
    Inventors: Jia Zhou, Allan R. Brasier, Bing Tian, Zhiqing Liu, Haiying Chen, Erik Rytting
  • Publication number: 20190359573
    Abstract: Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.
    Type: Application
    Filed: June 16, 2019
    Publication date: November 28, 2019
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Jia ZHOU, Allan R. BRASIER, Bing TIAN, Zhiqing LIU, Haiying CHEN, Erik RYTTING